Concentrix Statistics
Total Valuation
Concentrix has a market cap or net worth of $1.51 billion. The enterprise value is $5.64 billion.
| Market Cap | 1.51B |
| Enterprise Value | 5.64B |
Important Dates
The last earnings date was Tuesday, September 29, 2026, after market close.
| Earnings Date | Sep 29, 2026 |
| Ex-Dividend Date | Oct 23, 2026 |
Share Statistics
Concentrix has 60.95 million shares outstanding. The number of shares has decreased by -3.69% in one year.
| Current Share Class | 60.95M |
| Shares Outstanding | 60.95M |
| Shares Change (YoY) | -3.69% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 3.03% |
| Owned by Institutions (%) | 108.55% |
| Float | 47.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 2.15 |
| PS Ratio | 0.17 |
| Forward PS | 0.17 |
| PB Ratio | 0.93 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.21 |
| P/OCF Ratio | 2.21 |
| PEG Ratio | 0.44 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.06, with an EV/FCF ratio of 11.25.
| EV / Earnings | n/a |
| EV / Sales | 0.58 |
| EV / EBITDA | 5.06 |
| EV / EBIT | 11.68 |
| EV / FCF | 11.25 |
Financial Position
The company has a current ratio of 1.23, with a Debt / Equity ratio of 2.47.
| Current Ratio | 1.23 |
| Quick Ratio | 0.93 |
| Debt / Equity | 2.47 |
| Debt / EBITDA | 3.83 |
| Debt / FCF | 8.52 |
| Interest Coverage | 1.78 |
Financial Efficiency
Return on equity (ROE) is -78.22% and return on invested capital (ROIC) is 7.15%.
| Return on Equity (ROE) | -78.22% |
| Return on Assets (ROA) | 2.85% |
| Return on Invested Capital (ROIC) | 7.15% |
| Return on Capital Employed (ROCE) | 7.18% |
| Weighted Average Cost of Capital (WACC) | 5.50% |
| Revenue Per Employee | $21,911 |
| Profits Per Employee | -$5,263 |
| Employee Count | 455,000 |
| Asset Turnover | 0.92 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Concentrix has paid $62.90 million in taxes.
| Income Tax | 62.90M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.55% in the last 52 weeks. The beta is 0.51, so Concentrix's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -48.55% |
| 50-Day Moving Average | 26.99 |
| 200-Day Moving Average | 29.79 |
| Relative Strength Index (RSI) | 40.99 |
| Average Volume (20 Days) | 2,159,589 |
Short Selling Information
The latest short interest is 8.59 million, so 14.09% of the outstanding shares have been sold short.
| Short Interest | 8.59M |
| Short Previous Month | 9.37M |
| Short % of Shares Out | 14.09% |
| Short % of Float | 18.25% |
| Short Ratio (days to cover) | 6.64 |
Income Statement
In the last 12 months, Concentrix had revenue of $9.97 billion and -$2.39 billion in losses. Loss per share was -$39.08.
| Revenue | 9.97B |
| Gross Profit | 3.40B |
| Operating Income | 494.75M |
| Pretax Income | -2.33B |
| Net Income | -2.39B |
| EBITDA | 1.14B |
| EBIT | 494.75M |
| Loss Per Share | -$39.08 |
Balance Sheet
The company has $244.69 million in cash and $4.38 billion in debt, with a net cash position of -$4.13 billion or -$67.77 per share.
| Cash & Cash Equivalents | 244.69M |
| Total Debt | 4.38B |
| Net Cash | -4.13B |
| Net Cash Per Share | -$67.77 |
| Equity (Book Value) | 1.77B |
| Book Value Per Share | 29.02 |
| Working Capital | 546.42M |
Cash Flow
In the last 12 months, operating cash flow was $743.69 million and capital expenditures -$230.16 million, giving a free cash flow of $513.53 million.
| Operating Cash Flow | 743.69M |
| Capital Expenditures | -230.16M |
| Depreciation & Amortization | 646.21M |
| Net Borrowing | -340.56M |
| Free Cash Flow | 513.53M |
| FCF Per Share | $8.43 |
Margins
Gross margin is 34.08%, with operating and profit margins of 4.96% and -23.98%.
| Gross Margin | 34.08% |
| Operating Margin | 4.96% |
| Pretax Margin | -23.35% |
| Profit Margin | -23.98% |
| EBITDA Margin | 11.44% |
| EBIT Margin | 4.96% |
| FCF Margin | 5.14% |
Dividends & Yields
This stock pays an annual dividend of $1.48, which amounts to a dividend yield of 5.98%.
| Dividend Per Share | $1.48 |
| Dividend Yield | 5.98% |
| Dividend Growth (YoY) | 6.76% |
| Years of Dividend Growth | 4 |
| Payout Ratio | n/a |
| FCF Payout Ratio | 17.57% |
| Buyback Yield | 3.69% |
| Shareholder Yield | 9.17% |
| Earnings Yield | -145.47% |
| FCF Yield | 31.19% |
Analyst Forecast
The average price target for Concentrix is $33.50, which is 35.14% higher than the current price. The consensus rating is "Buy".
| Price Target | $33.50 |
| Price Target Difference | 35.14% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 0.70% |
| EPS Growth Forecast (3Y) | 3.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Concentrix has an Altman Z-Score of 1.32 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.32 |
| Piotroski F-Score | 5 |